Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies
Purpose of review - The most recent studies published or initiated in the last 18 months, investigating cannabidiol in the treatment of symptoms of schizophrenia and related conditions are summarized, including observed tolerability and reported side-effects. - Recent findings -...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2020
|
| In: |
Current opinion in psychiatry
Year: 2020, Jahrgang: 33, Heft: 3, Pages: 185-191 |
| ISSN: | 1473-6578 |
| DOI: | 10.1097/YCO.0000000000000596 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/YCO.0000000000000596 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-psychiatry/Abstract/2020/05000/Cannabidiol_as_a_treatment_option_for.2.aspx 
|
| Verfasserangaben: | Julie Schoevers, Judith E. Leweke, F. Markus Leweke |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1744333254 | ||
| 003 | DE-627 | ||
| 005 | 20240408193246.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210111s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/YCO.0000000000000596 |2 doi | |
| 035 | |a (DE-627)1744333254 | ||
| 035 | |a (DE-599)KXP1744333254 | ||
| 035 | |a (OCoLC)1341384962 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schoevers, Julie |e VerfasserIn |0 (DE-588)1224840402 |0 (DE-627)1744333823 |4 aut | |
| 245 | 1 | 0 | |a Cannabidiol as a treatment option for schizophrenia |b recent evidence and current studies |c Julie Schoevers, Judith E. Leweke, F. Markus Leweke |
| 264 | 1 | |c 2020 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.01.2021 | ||
| 520 | |a Purpose of review - The most recent studies published or initiated in the last 18 months, investigating cannabidiol in the treatment of symptoms of schizophrenia and related conditions are summarized, including observed tolerability and reported side-effects. - Recent findings - Recent studies focused on patients with sub-acute psychotic syndromes of schizophrenia, clinical high-risk state for psychosis (CHR-P), or frequent cannabis users, as well as cognitive functioning in chronic schizophrenia. There is further, although not consistent evidence for cannabidiol-reducing positive symptoms, but not negative symptoms. Evidence for improvement of cognition was weaker, with one study reporting a worsening. Regarding side effects and tolerability, cannabidiol induced sedation in one study, with the other studies indicating good tolerability, even at high doses. - Summary - Recent clinical trials added further evidence for an antipsychotic potential of cannabidiol. In general, studies following trial designs as suggested by regulators in schizophrenia are needed in sufficient numbers to clarify the safety and efficacy of cannabidiol herein. In addition, such studies will further elucidate its ability to target specific aspects of the syndrome, such as negative or cognitive symptoms. Furthermore, aiming for an add-on treatment with cannabidiol will require further studies to identify potentially useful or even harmful combinations. | ||
| 700 | 1 | |a Leweke, Judith E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leweke, F. Markus |e VerfasserIn |0 (DE-588)1052094287 |0 (DE-627)787796859 |0 (DE-576)407845941 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in psychiatry |d London : Lippincott Williams & Wilkins, 1988 |g 33(2020), 3, Seite 185-191 |h Online-Ressource |w (DE-627)32445578X |w (DE-600)2026976-6 |w (DE-576)093981112 |x 1473-6578 |7 nnas |a Cannabidiol as a treatment option for schizophrenia recent evidence and current studies |
| 773 | 1 | 8 | |g volume:33 |g year:2020 |g number:3 |g pages:185-191 |g extent:7 |a Cannabidiol as a treatment option for schizophrenia recent evidence and current studies |
| 856 | 4 | 0 | |u https://doi.org/10.1097/YCO.0000000000000596 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://journals.lww.com/co-psychiatry/Abstract/2020/05000/Cannabidiol_as_a_treatment_option_for.2.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210111 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1052094287 |a Leweke, F. Markus |m 1052094287:Leweke, F. Markus |d 60000 |e 60000PL1052094287 |k 0/60000/ |p 3 |y j | ||
| 999 | |a KXP-PPN1744333254 |e 3834261327 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"7 S."}],"relHost":[{"id":{"eki":["32445578X"],"issn":["1473-6578"],"zdb":["2026976-6"]},"pubHistory":["1.1988 -"],"recId":"32445578X","physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1988-","dateIssuedKey":"1988","publisherPlace":"London ; [Erscheinungsort nicht ermittelbar]"}],"note":["Gesehen am 13.12.06"],"language":["eng"],"disp":"Cannabidiol as a treatment option for schizophrenia recent evidence and current studiesCurrent opinion in psychiatry","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"volume":"33","year":"2020","extent":"7","text":"33(2020), 3, Seite 185-191","pages":"185-191","issue":"3"},"title":[{"title":"Current opinion in psychiatry","title_sort":"Current opinion in psychiatry"}]}],"title":[{"title_sort":"Cannabidiol as a treatment option for schizophrenia","title":"Cannabidiol as a treatment option for schizophrenia","subtitle":"recent evidence and current studies"}],"person":[{"given":"Julie","family":"Schoevers","display":"Schoevers, Julie","role":"aut"},{"display":"Leweke, Judith E.","role":"aut","given":"Judith E.","family":"Leweke"},{"family":"Leweke","given":"F. Markus","role":"aut","display":"Leweke, F. Markus"}],"origin":[{"dateIssuedDisp":"2020","dateIssuedKey":"2020"}],"note":["Gesehen am 11.01.2021"],"id":{"doi":["10.1097/YCO.0000000000000596"],"eki":["1744333254"]},"recId":"1744333254","type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Julie Schoevers, Judith E. Leweke, F. Markus Leweke"]},"language":["eng"]} | ||
| SRT | |a SCHOEVERSJCANNABIDIO2020 | ||